Secukinumab in an HIV-positive patient with psoriasis

J Dtsch Dermatol Ges. 2019 Jun;17(6):646-648. doi: 10.1111/ddg.13851. Epub 2019 May 17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • AIDS-Related Opportunistic Infections
  • Acquired Immunodeficiency Syndrome / complications*
  • Acquired Immunodeficiency Syndrome / drug therapy
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • Candidiasis / etiology
  • Drug Administration Schedule
  • Esophagitis / microbiology
  • Female
  • HIV Seropositivity / complications
  • Humans
  • Middle Aged
  • Psoriasis / complications
  • Psoriasis / drug therapy*
  • Remission Induction
  • Severity of Illness Index
  • Viral Load

Substances

  • Antibodies, Monoclonal, Humanized
  • secukinumab